{"id":42845,"date":"2025-10-30T11:15:46","date_gmt":"2025-10-30T10:15:46","guid":{"rendered":"https:\/\/www.boehmert.de\/?p=42845"},"modified":"2025-10-30T12:05:46","modified_gmt":"2025-10-30T11:05:46","slug":"european-biotechnology-fall-2025","status":"publish","type":"post","link":"https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/","title":{"rendered":"Challenges for the bio­pharma­ceutical sector posed by US policy \u2013 article by Dr. Ute Kilger in Euro­pean Bio­tech­nology"},"content":{"rendered":"

Article by Dr. Ute Kilger on the pressure exerted by the US government on the bio\u00adpharma\u00adceutical industry and the consequences.<\/h2>\n

In the fall 2025 issue of European Biotechnology, BOEHMERT & BOEHMERT partner and patent attorney Dr. Ute Kilger explains the impact of US policy on the pharmaceutical and biotech industries in her article \u201cChallenges for the biopharmaceutical sector posed by US policy\u201d.<\/p>\n

Dr. Kilger states that both the US and Europe are facing considerable challenges. Measures taken by the US government, such as the Inflation Reduction Act (IRA), the Orange Book initiative, the planned Most Favored Nation pricing regulation, and the proposed Trump-Lutnick patent tax, could hinder innovation and make investment in small molecule drugs unattractive.<\/p>\n

In doing so, US policy favors generic drug entry and puts innovative companies under pressure. European companies are also affected, especially those that are heavily dependent on the US market. The EU is pursuing similar trends but has toned down some proposals following criticism from industry. If Europe acts decisively, it could benefit from the US measures and overtake the US in terms of innovative strength, concludes Dr. Kilger.<\/p>\n

The full article by Dr. Kilger in English can be found in the fall issue of European Technology starting on page 33 and is available online here<\/a>.<\/p>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

Article by Dr. Ute Kilger on the pressure exerted by the US government on the bio\u00adpharma\u00adceutical industry and the consequences. In the fall 2025 issue of European Biotechnology, BOEHMERT & BOEHMERT partner and patent attorney Dr. Ute Kilger explains the…<\/p>","protected":false},"author":3,"featured_media":30841,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[210],"tags":[],"legal_areas":[224],"class_list":["post-42845","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publications","legal_areas-patents-and-utility-models"],"acf":[],"yoast_head":"\nDr. Ute Kilger: Challenges for the biopharmaceutical sector<\/title>\n<meta name=\"description\" content=\"Article by Dr. Ute Kilger on the pressure from the US government on the biopharmaceutical industry and the consequences. Read here!\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dr. Ute Kilger: Challenges for the biopharmaceutical sector\" \/>\n<meta property=\"og:description\" content=\"Article by Dr. Ute Kilger on the pressure from the US government on the biopharmaceutical industry and the consequences. Read here!\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"BOEHMERT & BOEHMERT\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-30T10:15:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-30T11:05:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.boehmert.de\/wp-content\/uploads\/2022\/06\/Kilger-Ute-Portrait-Web.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Petra Hettenkofer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Petra Hettenkofer\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/european-biotechnology-fall-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/european-biotechnology-fall-2025\\\/\"},\"author\":{\"name\":\"Petra Hettenkofer\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#\\\/schema\\\/person\\\/e46018db6ce9c808bc0f35de4a8cec19\"},\"headline\":\"Challenges for the bio­pharma­ceutical sector posed by US policy \u2013 article by Dr. Ute Kilger in Euro­pean Bio­tech­nology\",\"datePublished\":\"2025-10-30T10:15:46+00:00\",\"dateModified\":\"2025-10-30T11:05:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/european-biotechnology-fall-2025\\\/\"},\"wordCount\":240,\"publisher\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/european-biotechnology-fall-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.boehmert.de\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/Kilger-Ute-Portrait-Web.jpg\",\"articleSection\":[\"Publications\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/european-biotechnology-fall-2025\\\/\",\"url\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/european-biotechnology-fall-2025\\\/\",\"name\":\"Dr. Ute Kilger: Challenges for the biopharmaceutical sector\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/european-biotechnology-fall-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/european-biotechnology-fall-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.boehmert.de\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/Kilger-Ute-Portrait-Web.jpg\",\"datePublished\":\"2025-10-30T10:15:46+00:00\",\"dateModified\":\"2025-10-30T11:05:46+00:00\",\"description\":\"Article by Dr. Ute Kilger on the pressure from the US government on the biopharmaceutical industry and the consequences. Read here!\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/european-biotechnology-fall-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.boehmert.de\\\/en\\\/european-biotechnology-fall-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/european-biotechnology-fall-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.boehmert.de\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/Kilger-Ute-Portrait-Web.jpg\",\"contentUrl\":\"https:\\\/\\\/www.boehmert.de\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/Kilger-Ute-Portrait-Web.jpg\",\"width\":1000,\"height\":667,\"caption\":\"Dr. Ute Kilger, Patent Attorney\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/european-biotechnology-fall-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Challenges for the bio­pharma­ceutical sector posed by US policy \u2013 article by Dr. Ute Kilger in Euro­pean Bio­tech­nology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/\",\"name\":\"BOEHMERT & BOEHMERT\",\"description\":\"Intellectual property law firm\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#organization\",\"name\":\"BOEHMERT & BOEHMERT Anwaltspartnerschaft mbB\",\"alternateName\":\"BOEHMERT & BOEHMERT\",\"url\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.boehmert.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Logo-boehmert.webp\",\"contentUrl\":\"https:\\\/\\\/www.boehmert.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Logo-boehmert.webp\",\"width\":696,\"height\":172,\"caption\":\"BOEHMERT & BOEHMERT Anwaltspartnerschaft mbB\"},\"image\":{\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/de.linkedin.com\\\/company\\\/boehmert-&-boehmert\",\"https:\\\/\\\/www.xing.com\\\/pages\\\/boehmert-boehmertanwaltssozietat\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.boehmert.de\\\/en\\\/#\\\/schema\\\/person\\\/e46018db6ce9c808bc0f35de4a8cec19\",\"name\":\"Petra Hettenkofer\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dr. Ute Kilger: Challenges for the biopharmaceutical sector","description":"Article by Dr. Ute Kilger on the pressure from the US government on the biopharmaceutical industry and the consequences. Read here!","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/","og_locale":"en_US","og_type":"article","og_title":"Dr. Ute Kilger: Challenges for the biopharmaceutical sector","og_description":"Article by Dr. Ute Kilger on the pressure from the US government on the biopharmaceutical industry and the consequences. Read here!","og_url":"https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/","og_site_name":"BOEHMERT & BOEHMERT","article_published_time":"2025-10-30T10:15:46+00:00","article_modified_time":"2025-10-30T11:05:46+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/www.boehmert.de\/wp-content\/uploads\/2022\/06\/Kilger-Ute-Portrait-Web.jpg","type":"image\/jpeg"}],"author":"Petra Hettenkofer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Petra Hettenkofer"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/#article","isPartOf":{"@id":"https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/"},"author":{"name":"Petra Hettenkofer","@id":"https:\/\/www.boehmert.de\/en\/#\/schema\/person\/e46018db6ce9c808bc0f35de4a8cec19"},"headline":"Challenges for the bio­pharma­ceutical sector posed by US policy \u2013 article by Dr. Ute Kilger in Euro­pean Bio­tech­nology","datePublished":"2025-10-30T10:15:46+00:00","dateModified":"2025-10-30T11:05:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/"},"wordCount":240,"publisher":{"@id":"https:\/\/www.boehmert.de\/en\/#organization"},"image":{"@id":"https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.boehmert.de\/wp-content\/uploads\/2022\/06\/Kilger-Ute-Portrait-Web.jpg","articleSection":["Publications"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/","url":"https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/","name":"Dr. Ute Kilger: Challenges for the biopharmaceutical sector","isPartOf":{"@id":"https:\/\/www.boehmert.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.boehmert.de\/wp-content\/uploads\/2022\/06\/Kilger-Ute-Portrait-Web.jpg","datePublished":"2025-10-30T10:15:46+00:00","dateModified":"2025-10-30T11:05:46+00:00","description":"Article by Dr. Ute Kilger on the pressure from the US government on the biopharmaceutical industry and the consequences. Read here!","breadcrumb":{"@id":"https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/#primaryimage","url":"https:\/\/www.boehmert.de\/wp-content\/uploads\/2022\/06\/Kilger-Ute-Portrait-Web.jpg","contentUrl":"https:\/\/www.boehmert.de\/wp-content\/uploads\/2022\/06\/Kilger-Ute-Portrait-Web.jpg","width":1000,"height":667,"caption":"Dr. Ute Kilger, Patent Attorney"},{"@type":"BreadcrumbList","@id":"https:\/\/www.boehmert.de\/en\/european-biotechnology-fall-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.boehmert.de\/en\/"},{"@type":"ListItem","position":2,"name":"Challenges for the bio­pharma­ceutical sector posed by US policy \u2013 article by Dr. Ute Kilger in Euro­pean Bio­tech­nology"}]},{"@type":"WebSite","@id":"https:\/\/www.boehmert.de\/en\/#website","url":"https:\/\/www.boehmert.de\/en\/","name":"BOEHMERT & BOEHMERT","description":"Intellectual property law firm","publisher":{"@id":"https:\/\/www.boehmert.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.boehmert.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.boehmert.de\/en\/#organization","name":"BOEHMERT & BOEHMERT Anwaltspartnerschaft mbB","alternateName":"BOEHMERT & BOEHMERT","url":"https:\/\/www.boehmert.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.boehmert.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.boehmert.de\/wp-content\/uploads\/2026\/07\/Logo-boehmert.webp","contentUrl":"https:\/\/www.boehmert.de\/wp-content\/uploads\/2026\/07\/Logo-boehmert.webp","width":696,"height":172,"caption":"BOEHMERT & BOEHMERT Anwaltspartnerschaft mbB"},"image":{"@id":"https:\/\/www.boehmert.de\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/de.linkedin.com\/company\/boehmert-&-boehmert","https:\/\/www.xing.com\/pages\/boehmert-boehmertanwaltssozietat"]},{"@type":"Person","@id":"https:\/\/www.boehmert.de\/en\/#\/schema\/person\/e46018db6ce9c808bc0f35de4a8cec19","name":"Petra Hettenkofer"}]}},"_links":{"self":[{"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/posts\/42845","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/comments?post=42845"}],"version-history":[{"count":0,"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/posts\/42845\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/media\/30841"}],"wp:attachment":[{"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/media?parent=42845"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/categories?post=42845"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/tags?post=42845"},{"taxonomy":"legal_areas","embeddable":true,"href":"https:\/\/www.boehmert.de\/en\/wp-json\/wp\/v2\/legal_areas?post=42845"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}